Article Details

Nektar Therapeutics (NKTR) Analysts See $-0.43 EPS

Retrieved on: 2018-04-14 23:22:30

Tags for this article:

Click the tags to see associated articles and topics

Nektar Therapeutics (NKTR) Analysts See $-0.43 EPS. View article details on hiswai:

Excerpt

<div><b>Benchmark Capital</b> Advisors, a New York-based fund reported 70,650 shares. Tracking current trading session activity on shares of Nektar Therapeutics (NKTR), we can see that the stock price recently hit 104.27. About 679,246 shares traded. Select Income REIT (SIR) has declined 25.14% since April ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo